• N Yilmaz, F Tosun, E Comert, M Duran, and V D Tuna.
• Department of Anesthesia and Reanimation, Adiyaman Training and Research Hospital, Adiyaman, Turkey.
• Niger J Clin Pract. 2022 Oct 1; 25 (10): 1745-1750.

BackgroundThe C-reactive protein (CRP)/albumin ratio (CAR) is one of the new tools to assess the severity of inflammation. It is used to determine clinical severity and prognosis in many diseases.AimThe present study aimed to investigate the relationship between C-reactive protein (CRP)/albumin ratio (CAR) and prognosis in pregnant patients with more severe COVID-19 infection. Retrospective study.Patients And MethodsThe study was conducted in a retrospective manner by scanning the files of pregnant patients who had a positive polymerase chain reaction test result and were hospitalized in Adıyaman Training and Research Hospital. The patients were divided into two groups: patients who were admitted to the intensive care unit and patients who were not admitted. CRP/albumin ratio (CAR) levels were compared between these two groups. The cut-off value was determined in the prediction of intensive-care admission and poor prognosis.Results117 patient files were reviewed. 13 patients were followed up with intensive care, whereas 104 patients completed their treatment in the service. The CAR levels of the patients admitted to intensive care were significantly higher (P < 0.01). In the estimation of intensive-care admission, the CAR level was determined to be 0.970 in the area under the curve with 100% sensitivity and 86.5% specificity in the receiver operating characteristic (ROC) curve. The cut-off CAR level was calculated as 1.8.ConclusionCAR is a valuable biomarker for predicting prognosis, as well as follow-ups of pregnant COVID-19 patients.

13 keywords...

hide…